#CBD #Stock
News- CBD Unlimited (OTC: $EDXC) Invited for Exclusive Interview at Nasdaq
MarketSite in Times Square,
@CBDUnlimited_
CAVE CREEK, AZ, January 29,
2020 – (Investorideas.com
Newswire) CBD Unlimited,
Inc. (OTC: EDXC), formerly known as Endexx Corporation,
a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce the Company has been
invited for an exclusive interview taking place at the Nasdaq MarketSite in
Times Square, New York City on Wednesday, February 5th, 2020.
Mr. Todd Davis, CBD Unlimited’s Chairman and CEO,
will be addressing the Company’s recent business developments and rapid growth
of the CBD market. Once recorded, the interview will be released and
immediately accessible to the public. This interview comes quickly after the
Company’s new product suite launch and announcements of news related to
additional international markets.
Read this news for EDXC in full at https://www.investorideas.com/news/2020/cannabis/01291OTCEDXC.asp
“We are thrilled to have the opportunity to share
our recent developments and outlook for 2020 at the Nasdaq MarketSite in New
York City,” commented Todd Davis, CEO and Chairman of CBD Unlimited. “2019
proved to be a tremendous year for our Company and we look forward to updating
our audience on several new initiatives. Our team continues to cohesively
exceed expectations while innovating new products and delivering to our
customers. We look forward to sharing our updates directly from one of the top
exchanges in the world right in the heart of New York City.”
About CBD
Unlimited, Inc.
CBD
Unlimited, Inc. develops and distributes all-natural CBD products derived from
cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range
from oils, capsules, topicals, and pet products, all with the shared purpose of
therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews
for animal use that are formulated to promote health and support the reduction
of separation anxiety, pain, and inflammation. The science behind these
products involves over half a decade of research and experiments in order to
protect the accuracy in dosage and delivery of absorption per each serving.
In
the interest of providing conformity with federal and state mandates, the
company has incorporated the “Gorilla-Tek” platform into its business
practices. The Gorilla-Tek platform is the first standardized hardware agnostic
and software solution that tracks high-risk, high-shrink regulated, and
restricted products maintained under federal/state/local compliance. The
platform provides asset protection, inventory management, compliance and an
“end of sale” technology integration. Based on principles developed by the
pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously
efficient as it provides up-to-the-minute accounting and product details.
Gorilla-Tek increases productivity, while reducing costs for retailers and
costs in time for customers.
Safe Harbor Notice
This
press release may contain “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995, such as statements
relating to financial results and plans for future development activities and
are thus prospective. Forward-looking statements include all statements that
are not statements of historical fact regarding intent, belief or current
expectations of the company, its directors or its officers. Investors are
cautioned that any such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, many of which are beyond the
company’s ability to control. Actual results may differ materially from those
projected in the forward-looking statements. Among the factors that could cause
actual results to differ materially from those indicated in the forward-looking
statements are risks and uncertainties associated with the company’s business
and finances in general, including the ability to continue and manage its
growth, competition, global economic conditions and other factors discussed in
detail in the Company’s periodic filings with the Securities and Exchange
Commission. The company undertakes no obligation to update any forward-looking
statements.
Contact:
For further investor and media
information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
480-595-6900
Paid news Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. Disclosure : this news release featuring EDXC is
a paid for news release on Investorideas.com
https://www.investorideas.com/News-Upload/
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and
our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
